Company profile
Neuphoria Therapeutics Inc. Insider Trading
NEUPEvery SEC Form 4 insider trading filing for Neuphoria Therapeutics Inc. (NEUP) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001191070
- Filings
- 12
- Insiders
- 7
- Last filing
- 2026-01-20
Activity summary
No insider transactions in the last 30 days. The most recent was on January 20, 2026, when Peter Miles Winston Davies reported 8,537 shares (Award). 12 filings from 7 insiders are on record below.
Quarterly balance
Buy and sell value by quarter, Q2 25 to Q1 26. Neuphoria Therapeutics Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $3.3M.
No insider activity recorded for NEUP in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 20, 2026 | Peter Miles Winston Davies | NEUP | Award | 8,537 | — | — |
| Jan 20, 2026 | Alan Fisher | NEUP | Award | 17,073 | — | — |
| Jan 20, 2026 | Jane Ryan | NEUP | Award | 8,537 | — | — |
| Jan 20, 2026 | David Ian Wilson | NEUP | Award | 8,537 | — | — |
| Oct 21, 2025 | Lynx1 Capital Management LP | NEUP | Purchase | 639,110 | $5.14 | $3.28M |
6 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=NEUP" \
-H "X-Api-Key: $KEY"Institutional Ownership
Top 13F-HR holders of Neuphoria Therapeutics Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →